| Literature DB >> 25662009 |
David H McDermott1, Ji-Liang Gao1, Qian Liu1, Marie Siwicki1, Craig Martens2, Paejonette Jacobs1, Daniel Velez1, Erin Yim1, Christine R Bryke3, Nancy Hsu3, Zunyan Dai4, Martha M Marquesen5, Elina Stregevsky6, Nana Kwatemaa5, Narda Theobald5, Debra A Long Priel7, Stefania Pittaluga8, Mark A Raffeld8, Katherine R Calvo9, Irina Maric9, Ronan Desmond10, Kevin L Holmes6, Douglas B Kuhns7, Karl Balabanian11, Françoise Bachelerie11, Stephen F Porcella2, Harry L Malech5, Philip M Murphy12.
Abstract
Chromothripsis is a catastrophic cellular event recently described in cancer in which chromosomes undergo massive deletion and rearrangement. Here, we report a case in which chromothripsis spontaneously cured a patient with WHIM syndrome, an autosomal dominant combined immunodeficiency disease caused by gain-of-function mutation of the chemokine receptor CXCR4. In this patient, deletion of the disease allele, CXCR4(R334X), as well as 163 other genes from one copy of chromosome 2 occurred in a hematopoietic stem cell (HSC) that repopulated the myeloid but not the lymphoid lineage. In competitive mouse bone marrow (BM) transplantation experiments, Cxcr4 haploinsufficiency was sufficient to confer a strong long-term engraftment advantage of donor BM over BM from either wild-type or WHIM syndrome model mice, suggesting a potential mechanism for the patient's cure. Our findings suggest that partial inactivation of CXCR4 may have general utility as a strategy to promote HSC engraftment in transplantation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25662009 PMCID: PMC4329071 DOI: 10.1016/j.cell.2015.01.014
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582